By addressing the root causes of metabolic dysfunction, tirzepatide can help reduce the risk of several obesity-related conditions, including: Non-alcoholic Fatty Liver Disease (NAFLD) For individuals struggling with both weight and metabolic issues, this medication represents a major therapeutic advancement
Semaglutide (Wegovy): Wegovy is the brand name for semaglutide specifically designed for obesity treatment
The Broad Institute Connectivity Map analysis of GHK-driven gene-expression shifts 9
Similarly, Eric Polley, PhD, a UChicago data science and public health expert, recently led a study published in Nature Cardiovascular Research that used statistical modeling to emulate a clinical trial comparing the effects of four different classes of diabetes medication in patients with moderate cardiovascular risk
Discussing these effects with a healthcare professional can help find solutions or alternative therapies
Noom discloses pharmacy details on request, and its compounded medication is sourced through state-regulated pharmacies